Fergus W Gardiner1, Elizabeth Regan2, Ezekiel U Nwose3, Phillip T Bwititi4, Judith Crockett3, Lexin Wang4. 1. School of Community Health, Charles Sturt University, Australia; Calvary Hospital, ACT, Australia; School of Biomedical Sciences, Charles Sturt University, Australia. Electronic address: gus_gardiner@hotmail.com. 2. Calvary Hospital, ACT, Australia. 3. School of Community Health, Charles Sturt University, Australia. 4. School of Biomedical Sciences, Charles Sturt University, Australia.
Abstract
OBJECTIVE: To determine if the Cardiac rehabilitation (CR) program had positive effects on the patient medically as well as effects on pathological risk factors, functional capacity, and mental health; and the extent to which targets for blood pressure (BP) control in patients with hypertension (HT) and diabetes mellitus (DM) are achieved. METHODOLOGY: CR participant data was collected from 1st June 2014 until 31st December 2015 (19 months), which included: demographics, medical history, social history, medications, lipid profiles and anthropometric measurements. Additional data was collected on The Patient Health Questionnaire (PHQ-9) factors, and on the participants 6min walk test (6MWT). Study participants were eligible to participate in the study if they attended 10 or more CR program sessions out of 12 at the Calvary Public Hospital Canberra. RESULTS: Seventy nine (79) participants participated in the study. Significant reductions in BP (n=79) (p=<0.05), blood LDL cholesterol levels (n=26) (p=<0.05), and improvements in participants PHQ-9 scores (n=79) (p=<0.001), and their 6MWT (n=78) (p=<0.001) were noted. Participants were also able to better manage their medication (p=<0.05). Importantly, results indicated that significant improvements (p=<0.05) were made in DM patients (n=18) diastolic BP, physical ability and depression and anxiety. CONCLUSION: A CR program can reduce risk factors associated with CVD, and improves mental health and physical fitness of participants. RESULTS: Indicated that the CR program reduces DM patient risk factors through improved physical fitness and reductions in depression and anxiety, leading to reduced risk of future cardiovascular and renal disease.
OBJECTIVE: To determine if the Cardiac rehabilitation (CR) program had positive effects on the patient medically as well as effects on pathological risk factors, functional capacity, and mental health; and the extent to which targets for blood pressure (BP) control in patients with hypertension (HT) and diabetes mellitus (DM) are achieved. METHODOLOGY: CR participant data was collected from 1st June 2014 until 31st December 2015 (19 months), which included: demographics, medical history, social history, medications, lipid profiles and anthropometric measurements. Additional data was collected on The Patient Health Questionnaire (PHQ-9) factors, and on the participants 6min walk test (6MWT). Study participants were eligible to participate in the study if they attended 10 or more CR program sessions out of 12 at the Calvary Public Hospital Canberra. RESULTS: Seventy nine (79) participants participated in the study. Significant reductions in BP (n=79) (p=<0.05), blood LDL cholesterol levels (n=26) (p=<0.05), and improvements in participants PHQ-9 scores (n=79) (p=<0.001), and their 6MWT (n=78) (p=<0.001) were noted. Participants were also able to better manage their medication (p=<0.05). Importantly, results indicated that significant improvements (p=<0.05) were made in DMpatients (n=18) diastolic BP, physical ability and depression and anxiety. CONCLUSION: A CR program can reduce risk factors associated with CVD, and improves mental health and physical fitness of participants. RESULTS: Indicated that the CR program reduces DMpatient risk factors through improved physical fitness and reductions in depression and anxiety, leading to reduced risk of future cardiovascular and renal disease.
Authors: Andrea Denegri; Valentina A Rossi; Fabrizio Vaghi; Paolo Di Muro; Martino Regazzi; Tiziano Moccetti; Elena Pasotti; Giovanni B Pedrazzini; Mauro Capoferri; Marco Moccetti Journal: Cardiol J Date: 2020-02-10 Impact factor: 2.737